Patents by Inventor Antonio Pellicer-Martinez

Antonio Pellicer-Martinez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE EXPRESSION PROFILE AS AN ENDOMETRIAL RECEPTIVITY MARKER
    Publication number: 20190276890
    Abstract: The present invention relates to determining the receptivity of human endometrium from a gene expression profile. More specifically, the invention consists of developing a specific expression microarray of endometrial receptivity (Endometrial Receptivity Array or ERA) which allows evaluating the receptive state of a human endometrium, as well as assessing said state for diagnostic and therapeutic purposes.
    Type: Application
    Filed: September 24, 2018
    Publication date: September 12, 2019
    Applicant: IGENOMIX S.L.
    Inventors: Carlos Simón Vallés, José Horcajadas Almansa, Patricia Diaz Gimeno, Antonio Pellicer Martínez
  • Gene expression profile as an endometrial receptivity marker
    Patent number: 10081840
    Abstract: The present invention relates to determining the receptivity of human endometrium from a gene expression profile. More specifically, the invention consists of developing a specific expression microarray of endometrial receptivity (Endometrial Receptivity Array or ERA) which allows evaluating the receptive state of a human endometrium, as well as assessing said state for diagnostic and therapeutic purposes.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: September 25, 2018
    Assignee: Igenomix S.L.
    Inventors: Carlos Simón Vallés, José Antonio Horcajadas Almansa, Patricia Díaz Gimeno, Antonio Pellicer Martínez
  • Medicament for the treatment of endometriosis
    Patent number: 9023862
    Abstract: The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: May 5, 2015
    Assignee: Ferring International Center S.A.
    Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre
  • Medicament For The Treatment Of Endometriosis
    Publication number: 20150073010
    Abstract: The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
    Type: Application
    Filed: November 17, 2014
    Publication date: March 12, 2015
    Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre
  • Medicament for the treatment of endometriosis
    Patent number: 8927568
    Abstract: The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
    Type: Grant
    Filed: February 1, 2008
    Date of Patent: January 6, 2015
    Assignee: Ferring International Center S.A.
    Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre
  • TREATMENT OF ENDOMETRIOSIS
    Publication number: 20140194460
    Abstract: A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.
    Type: Application
    Filed: August 7, 2013
    Publication date: July 10, 2014
    Applicant: Ferring B.V.
    Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre, Joan Carles Arce Saez
  • DIAGNOSTIC METHOD FOR ENDOMETRIAL RECEPTIVITY
    Publication number: 20130144114
    Abstract: The invention relates to a non-invasive diagnostic method of endometrial receptivity which includes collecting and comparing lipid biomarker patterns to reference lipidomic biomarkers, particularly prostaglandins PGE2 and/or PGF2?. The method is especially applicable for determining status fertility of a mammalian female, preferably, a woman.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 6, 2013
    Applicant: Equipo IVI Investigación S.L.
    Inventors: Carlos Simón Vallés, Antonio Pellicer Martínez, Óscar Berlanga Atienza
  • Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist
    Patent number: 8334298
    Abstract: Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: April 24, 2006
    Date of Patent: December 18, 2012
    Assignee: Ferring International Center S.A.
    Inventors: Antonio Pellicer-Martinez, Joan-Carles Arce, Carlos Simon-Valles, Raul Gomez-Gallego
  • TREATMENT OF ENDOMETRIOSIS
    Publication number: 20120157489
    Abstract: A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.
    Type: Application
    Filed: June 25, 2010
    Publication date: June 21, 2012
    Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre, Joan Carlos Arce Saez
  • GENE EXPRESSION PROFILE AS AN ENDOMETRIAL RECEPTIVITY MARKER
    Publication number: 20120040849
    Abstract: The present invention relates to determining the receptivity of human endometrium from a gene expression profile. More specifically, the invention consists of developing a specific expression microarray of endometrial receptivity (Endometrial Receptivity Array or ERA) which allows evaluating the receptive state of a human endometrium, as well as assessing said state for diagnostic and therapeutic purposes.
    Type: Application
    Filed: July 22, 2009
    Publication date: February 16, 2012
    Applicant: EQUIPO IVI INVESTIGACION SL
    Inventors: Carlos Simón Valles, José Antonio Horcajadas Almansa, Patricia Diaz Gimeno, Antonio Pellicer Martínez
  • MEDICAMENT FOR THE TREATMENT OF ENDOMETRIOSIS
    Publication number: 20100113499
    Abstract: The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
    Type: Application
    Filed: February 1, 2008
    Publication date: May 6, 2010
    Applicant: FERRING INTERNATIONAL CENTER S.A.
    Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre
  • Treatment or Prevention of Ovarian Hyperstimulation Syndrome (Ohss) Using a Dopamine Agonist
    Publication number: 20080293693
    Abstract: Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 24, 2006
    Publication date: November 27, 2008
    Applicant: Ferring International Center S.A.
    Inventors: Antonio Pellicer-Martinez, Joan-Carles Arce, Carlos Simon-Valles, Raul Gomez-Gallego